01 1ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
02 1ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
03 7ALPROSTADIL
04 1ASPIRIN; OXYCODONE HYDROCHLORIDE
05 2ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE
06 1Acetylsalicylic Acid; Dipyridamole
07 1CLINDAMYCIN PHOSPHATE
08 2CYANOCOBALAMIN
09 1DALBAVANCIN (DALBAVANCIN HYDROCHLORIDE)
10 1FOMEPIZOLE
11 1FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE)
12 2FROVATRIPTAN (FROVATRIPTAN SUCCINATE)
13 1FROVATRIPTAN SUCCINATE
14 2HISTRELIN ACETATE
15 1ISOSORBIDE DINITRATE
16 1MEGESTROL ACETATE
17 2METHOCARBAMOL
18 2METHOXYFLURANE
19 7OXYMORPHONE HYDROCHLORIDE
20 2PENBUTOLOL SULFATE
21 2PITOLISANT HYDROCHLORIDE
22 1SINECATECHINS
23 2SUMATRIPTAN SUCCINATE
24 3TESTOSTERONE
25 1TESTOSTERONE UNDECANOATE
26 4THEOPHYLLINE
27 1Testosteron
28 1Testosterone
29 1VALRUBICIN
30 3Zonisamide
01 2BOCA PHARMA LLC
02 40ENDO OPERATIONS
03 10ENDO OPERATIONS LTD.
04 5Endo Ventures Limited
05 1Endo Ventures Unlimited Company
01 5CAPSULE, EXTENDED RELEASE;ORAL
02 1CAPSULE;ORAL
03 1Capsule For Inhalation
04 1GEL, METERED;NASAL
05 1GEL, METERED;TRANSDERMAL
06 1GEL;TRANSDERMAL
07 3Hard Capsule
08 2IMPLANT;SUBCUTANEOUS
09 7INJECTABLE;INJECTION
10 1INJECTABLE;INTRAMUSCULAR
11 2INJECTABLE;SUBCUTANEOUS
12 1KIT
13 1LIQUID
14 1OINTMENT
15 1PELLET;IMPLANTATION
16 2POWDER FOR SOLUTION
17 1SOLUTION
18 1SOLUTION;INTRAVESICAL
19 1SOLUTION;TOPICAL
20 1SPRAY, METERED;NASAL
21 1SUSPENSION;ORAL
22 4TABLET
23 7TABLET, EXTENDED RELEASE;ORAL
24 9TABLET;ORAL
25 2Transdermal Gel
01 10.005MG/VIAL
02 20.01MG/VIAL
03 20.02MG/VIAL
04 20.04MG/VIAL
05 10.5MG/INH
06 10.5MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
07 110%/W/W
08 2100MG
09 210MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
10 110MG/0.5GM ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
11 1125MG/ML
12 115MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
13 11G/ML
14 22.5MG
15 1200MG
16 1200mg;25mg
17 120MG
18 220MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
19 125MG
20 1300MG
21 130MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
22 1325MG;2.25MG;0.19MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
23 1325MG;4.5MG;0.38MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
24 1325MG;4.8355MG
25 13G/SACHET
26 1400MG
27 140MG
28 140MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
29 140MG/ML
30 1500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
31 1500MG/VIAL
32 450MG
33 150MG/5GM PACKET
34 150mg
35 15MG
36 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
37 17.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
38 1712.8MG;60MG;32MG
39 1750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
40 1750MG/3ML (250MG/ML)
41 175MG
42 18MG;60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
43 299.9%
44 1EQ 1% BASE
45 1EQ 2.5MG BASE
46 1EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML)
47 1EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
01 10Canada
02 3Malta
03 1Spain
04 2Sweden
05 42USA
Regulatory Info : DISCN
Registration Country : USA
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Dosage Form : TABLET;ORAL
Brand Name : ACETAMINOPHEN, CAFFEINE, ...
Dosage Strength : 712.8MG;60MG;32MG
Packaging :
Approval Date : 2007-04-03
Application Number : 40701
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Deregistered
Registration Country : Sweden
Acetylsalicylic Acid; Dipyridamole
Dosage Form : Capsule For Inhalation
Brand Name : Atranipar
Dosage Strength : 200mg;25mg
Packaging :
Approval Date : 22-09-2017
Application Number : 2.02E+13
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : DISCN
Registration Country : USA
ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Brand Name : SEMPREX-D
Dosage Strength : 8MG;60MG **Federal Reg...
Packaging :
Approval Date : 1994-03-25
Application Number : 19806
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.005MG/VIAL
Packaging :
Approval Date : 1997-06-12
Application Number : 20649
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.01MG/VIAL
Packaging :
Approval Date : 1997-06-12
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.02MG/VIAL
Packaging :
Approval Date : 1997-06-12
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.04MG/VIAL
Packaging :
Approval Date : 1997-06-12
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.01MG/VIAL
Packaging :
Approval Date : 1998-07-30
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.02MG/VIAL
Packaging :
Approval Date : 1998-07-30
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : EDEX
Dosage Strength : 0.04MG/VIAL
Packaging :
Approval Date : 1998-07-30
Application Number : 20649
Regulatory Info : RX
Registration Country : USA
Endo International is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find Glycopyrronium Bromide bulk offered by Endo International
